Work

Safety of Serial Monthly Administration of Triple-Dose Gadopentetate Dimeglumine in Multiple Sclerosis Patients: Preliminary Results of the BECOME Trial

FWCI: 0.67
Cites: 4
Cited by: 12
Related to: 10